Management in patients with type 2 diabetes: A randomized clinical trial

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 7, 2015, Pages 2546-2556

  Ding, Su Ann ^a,b   Simonson, Donald C ^a,c   Wewalka, Marlene ^a,b   Halperin, Florencia ^a,c   Foster, Kathleen ^a,b   Goebel Fabbri, Ann ^a,b   Hamdy, Osama ^a,b   Clancy, Kerri ^c   Lautz, David ^a,b   Vernon, Ashley ^a,c   Goldfine, Allison B ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JOSLIN DIABETES CENTER   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; CREATININE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BARRIERS TO BEING ACTIVE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; EURO QOL 5 DIMENSIONS; EXERCISE; FEMALE; FITNESS; FOLLOW UP; FUNCTIONAL STATUS ASSESSMENT; GASTRIC BANDING; GLUCOSE BLOOD LEVEL; HIATUS HERNIA; HUMAN; HYPOGLYCEMIA; IMPACT OF WEIGHT ON QUALITY OF LIFE; ISCHEMIC HEART DISEASE; LENGTH OF STAY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; PRIORITY JOURNAL; PROBLEM AREAS IN DIABETES; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; SYRINGOMYELIA; SYSTOLIC BLOOD PRESSURE; TREATMENT REFUSAL; WEIGHT REDUCTION; CLINICAL TRIAL; COMPLICATION; DEVICES; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; GASTROPLASTY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; OBESITY, MORBID; YOUNG ADULT;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; GASTROPLASTY; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OBESITY, MORBID; WEIGHT LOSS; YOUNG ADULT;

EID: 84953911691     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1443     Document Type: Article

References (40)

1. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254: 410-420; discussion 420-422.
2. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-256. e5.
3. Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014;312:934-942.
4. Pinkney JH, Johnson AB, Gale EA. The big fat bariatric bandwagon. Diabetologia. 2010;53:1815-1822.
5. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.
6. Look AHEAD Research Group, Wing RR. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med. 2010;170:1566-1575.
7. Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U. S. diabetes care, 1999-2010. NEngl J Med. 2013;368:1613-1624.
8. Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014;149:716-726.
9. Look AHEAD Research Group, Wadden TA, West DS, Delahanty L, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it. Obesity (Silver Spring). 2006;14:737-752.
10. LookAHEADResearch Group, Pi-Sunyer X, Blackburn G, Brancati FL, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30:1374-1383.
11. Hamdy O, Carver C. The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes. Curr Diab Rep. 2008;8:413-420.
12. Giusti J, Rizzotto JA. Interpreting the Joslin Diabetes Center and Joslin Clinic Clinical nutrition guideline for overweight and obese adults with type 2 diabetes. Curr Diab Rep. 2006;6:405-408.
13. Beriault K, Carpentier AC, Gagnon C, et al. Reproducibility of the 6-minute walk test in obese adults. Int J Sports Med. 2009;30:725-727.
14. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40-66.
15. Barriers to Being Active Quiz. Centers for Disease Control and Prevention web site. http://www. cdc. gov/diabetes/ndep/pdfs/8-roadto-health-barriers-quiz-508. pdf. Accessed February 7, 2015.
16. EuroQol Group Association web site. http://www. euroqol. org/ about-eq-5d. html. Accessed February 7, 2015.
17. Welch G, Weinger K, Anderson B, PolonskyWH. Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire. Diabet Med. 2003;20:69-72.
18. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18:754-760.
19. Kolotkin RL, Crosby RD. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample. Qual Life Res. 2002;11:157-171.
20. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes. 1979;28:1039-1057.
21. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-323.
22. Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg. 2014;149:707-715.
23. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA. 2013;309:2240-2249.
24. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-1576.
25. Mingrone G, Panunzi S,DeGaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-1585.
26. Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term Outcomes of bariatric surgery: a National Institutes of Health Symposium. JAMA Surg. 2014;149:1323-1329.
27. Lautz D, Halperin F, Goebel-Fabbri A, Goldfine AB. The great debate: medicine or surgery: what is best for the patient with type 2 diabetes? Diabetes Care. 2011;34:763-770.
28. VetterML,Cardillo S, RickelsMR,Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med. 2009;150:94-103.
29. Wang GF, Yan YX, Xu N, et al. Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis. Obes Surg. 2015;25:199-208.
30. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309:2250-2261.
31. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23:93-102.
32. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577-1589.
33. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580-591.
34. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753-761.
35. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007; 357:741-752.
36. Sjöström L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56-65.
37. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763-1777.
38. Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216:545-556; discussion 556-548.
39. Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399-405.
40. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23:427-436.